The pharmaceutical industry is undergoing a profound transformation. As regulatory expectations continue to evolve, drug ...

According to MarketsandMarkets™, the Research Use Recombinant Protein Market is projected to reach USD 1.55 billion by 2031 from USD 1.11 billion in 2026, at a CAGR of 7.0% during the forecast period.

A methodology-led guide comparing five specialist firms across launch readiness, market access, competitive response ...

In the competitive pharmaceutical and biotechnology industries, where robust patent portfolios are essential for protecting innovative biologics and enabling successful biosimilar development and ...

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions ...

Stronger collaboration with Chinese pharmaceutical companies can help Pakistan enhance its technological capabilities, expand ...

The Biosecure Act, introduced in January 2024 (H.R. 7085), has garnered significant bipartisan support and is increasingly poised to become law, heightening its impact on the life sciences industry.

JLL says sovereign funding, regulatory reforms and specialised clusters are accelerating pharmaceutical manufacturing, ...

Beijing has unveiled a plan for its International BioPark in the Beijing Economic-Technological Development Area, also known ...

The rapid growth of Biotechnology, Pharmaceutical Sciences and allied healthcare fields has triggered a high demand for professionals equipped with specialized knowledge, practical skills and industry ...

State Key Laboratory of Pharmaceutical Biotechnology, HKU has the following research output in the current window (1 April 2025 - 31 March 2026) of the Nature Index. Click on Count to view a list of ...